195 related articles for article (PubMed ID: 31047570)
21. Comparison between glaucomatous and non-glaucomatous eyes with unilateral retinal vein occlusion in the fellow eye.
Kim S; Sung KR; Joe SG; Kim JT; Lee DH; Lee JY; Kim JG
Korean J Ophthalmol; 2013 Dec; 27(6):440-5. PubMed ID: 24311930
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion.
Campochiaro PA; Bhisitkul RB; Shapiro H; Rubio RG
Ophthalmology; 2013 Apr; 120(4):795-802. PubMed ID: 23260261
[TBL] [Abstract][Full Text] [Related]
23. The fellow eye in retinal vein occlusive disease.
Pollack A; Dottan S; Oliver M
Ophthalmology; 1989 Jun; 96(6):842-5. PubMed ID: 2787012
[TBL] [Abstract][Full Text] [Related]
24. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.
Hayreh SS; Zimmerman MB; Beri M; Podhajsky P
Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive, High-Resolution Functional Macular Imaging in Subjects With Retinal Vein Occlusion.
Campagnoli TR; Somfai GM; Tian J; DeBuc DC; Smiddy WE
Ophthalmic Surg Lasers Imaging Retina; 2017 Oct; 48(10):799-809. PubMed ID: 29020423
[TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
[TBL] [Abstract][Full Text] [Related]
27. Are inner nuclear layer ischemic lesions hidden indicators of retinal vein occlusion risk? A case-control study.
Nourinia R; Mashhadi SM; Abtahi SH; Nouri H
Int J Retina Vitreous; 2023 Jul; 9(1):39. PubMed ID: 37408057
[TBL] [Abstract][Full Text] [Related]
28. Hypertension, hyperlipidaemia and thrombophilia as the most common risk factors for retinal vein occlusion in patients under 50 years.
Schreiberova Z; Rehak J; Babkova B; Sin M; Rybarikova M; Paskova B; Sinova I; Hubnerova P; Maluskova M; Maresova K; Karhanova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):44-49. PubMed ID: 36036564
[TBL] [Abstract][Full Text] [Related]
29. The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study.
Zhou JQ; Xu L; Wang S; Wang YX; You QS; Tu Y; Yang H; Jonas JB
Ophthalmology; 2013 Apr; 120(4):803-8. PubMed ID: 23352194
[TBL] [Abstract][Full Text] [Related]
30. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
[TBL] [Abstract][Full Text] [Related]
31. Retinal vein occlusion in Armenia.
Malayan AS; Shakhsuvaryan ML; Grigoryan GL; Melkonyan AK
Eur J Ophthalmol; 1999; 9(3):196-201. PubMed ID: 10544974
[TBL] [Abstract][Full Text] [Related]
32. Baseline characteristics and risk factors of retinal vein occlusion: a study by the Korean RVO Study Group.
Lee JY; Yoon YH; Kim HK; Yoon HS; Kang SW; Kim JG; Park KH; Jo YJ;
J Korean Med Sci; 2013 Jan; 28(1):136-44. PubMed ID: 23341724
[TBL] [Abstract][Full Text] [Related]
33. Conversion from nonischemic to ischemic retinal vein occlusion: prediction by venous velocity on color Doppler imaging.
Arsene S; Vierron E; Le Lez ML; Herault B; Gruel Y; Pisella PJ; Giraudeau B; Tranquart F
Eur J Ophthalmol; 2009; 19(6):1009-16. PubMed ID: 19882574
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.
Campochiaro PA; Sophie R; Pearlman J; Brown DM; Boyer DS; Heier JS; Marcus DM; Feiner L; Patel A;
Ophthalmology; 2014 Jan; 121(1):209-219. PubMed ID: 24112944
[TBL] [Abstract][Full Text] [Related]
35. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
36. Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion.
Lloyd Clark W; Liu M; Kitchens J; Wang PW; Haskova Z
BMC Ophthalmol; 2019 Jan; 19(1):11. PubMed ID: 30621653
[TBL] [Abstract][Full Text] [Related]
37. Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions.
Appiah AP; Trempe CL
Ophthalmology; 1989 Mar; 96(3):364-6. PubMed ID: 2710528
[TBL] [Abstract][Full Text] [Related]
38. Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year.
Arséne S; Giraudeau B; Le Lez ML; Pisella PJ; Pourcelot L; Tranquart F
Br J Ophthalmol; 2002 Nov; 86(11):1243-7. PubMed ID: 12386080
[TBL] [Abstract][Full Text] [Related]
39. Axial length and hyperopia in eyes with retinal vein occlusions.
Kir E; Tülin Berk A; Osman Saatci A; Kaynak S; Ergin MH
Int Ophthalmol; 1997-1998; 21(4):209-11. PubMed ID: 9700008
[TBL] [Abstract][Full Text] [Related]
40. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
Guo S; Ren J; Li Z; Fan X; Qin L; Li J
Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
